Pauline M. Maki, PhD, introduces OPTION-VMS and explains why real-world data are needed to test whether randomized trial ...
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood ...
Pauline M. Maki, PhD, reviews the first data cuts from OPTION-VMS, released at The Menopause Society 2025 meeting. These ...
RAD 2025: Multidisciplinary collaboration at disease-specific meetings drives clinical and therapeutic progress in AD, Dr Yu told Patient Care. Dermatologists aren't trained in mental health but once ...
In "Shared Decision-Making for Agitation in Specialty Care and Disease Trajectory," our experts close out the discussion of ...
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while ...
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication ...
A multicomponent approach to vaccination distress works across the lifespan, though how it works depends on age, according to ...
"Starting the HIV PrEP Conversation in Primary Care and Pharmacy" takes up the question of how clinicians and pharmacists can start the PrEP conversation, and who should be having it.
The faculty compare testing strategies across clinical and pharmacy settings. This episode, "HIV Testing Before and During PrEP: Getting It Right," features the faculty walking through baseline and ...
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results